While there have been no studies conducted on Maxair and breastfeeding, it is believed that the medicine is probably safe for most women who are breastfeeding. Make sure to talk with your healthcare provider about the risks and benefits of using the medication while nursing. If you are using Maxair and breastfeeding, you should watch for side effects in your baby.
An Overview of Maxair and Breastfeeding
It is not known if Maxair® (pirbuterol acetate) is passed through breast milk. Because of the potentially serious side effects that could occur in the nursing infant, the manufacturer of Maxair recommends that healthcare providers consider the possible risks and benefits before recommending Maxair to a woman who is breastfeeding. Therefore, if you are breastfeeding or thinking of breastfeeding and have been prescribed Maxair, make sure to let your healthcare provider know.
Maxair inhalers will not be made, dispensed, or sold in the United States in their current form after December 31, 2013. Maxair contains chlorofluorocarbons (CFCs), chemicals that deplete the ozone layer. The U.S. Food and Drug Administration (FDA) has set this final date for the medication in order to comply with the Montreal Protocol on Substances That Deplete the Ozone Layer. The manufacturer of Maxair is working on a reformulated, CFC-free version, although it is not yet clear when that product will be available to consumers.
What Does the Research Say About Maxair and Breastfeeding?
No research has been done to see if Maxair is passed through breast milk. However, it is thought that Maxair is probably safe for most women who are breastfeeding. If your healthcare provider recommends taking Maxair while breastfeeding, be sure to watch for any side effects in your child.
National Library of Medicine (US). Drugs and Lactation Database (LactMED). NLM Web site. Available at: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT. Accessed April 6, 2007.
Food and Drug Administration, Center for Drug Evaluation and Research. Asthma and COPD inhalers that contain ozone-depleting CFCs to be phased out; alternative treatments available (4/13/2010). FDA Web site. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm208302.htm. Accessed April 16, 2010.
Graceway Pharmaceuticals. Statement on the continued availability of Maxair Autohaler (pirbuterol acetate inhalation aerosol). Maxair Web site. Available at: http://www.maxair.com/MAXStillAvailable.pdf. Accessed April 16, 2010.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click